SØren MØller
PhD
Oncology
RSPR
Sweden
Biography
Søren obtained his MSc degree from the Technical University of Denmark in 1993 and his PhD degree in molecular biology in 1997 from the Technical University of Denmark. In addition, Søren has academic training as postdoctoral fellow at Stanford University School of Medicine. Prior to joining Novo Seeds in 2011, Søren served as global manager of Bioinformatics and Genomics at Novozymes. Before Novozymes, Søren was CSO and Vice President of R&D at Exiqon A/S where he was responsible for development of microRNA based products. Previously, Søren worked in cancer drug development as head of Lead Identification at BioImage and as research scientist at Novo Nordisk.
Research Interest
Besides RSPR Pharma Søren serves on the Board of Directors of Biosyntia, Denator AB, and Reapplix A/S. And since 2008, Søren has been board member of Danish Biotech (the Association of Biotechnology Industries in Denmark)
